Form 4 for WST West Pharmaceutical Services
Accepted 2024-08-21 00:00:00 ET · period of report 2024-08-19 · accession 0001127602-24-022725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-21 | 2024-08-19 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $300.00 | -1,029 | 1,978 | -34% | -$308.7K |
| D | 2024-08-21 | 2024-08-19 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $102.51 | +529 | 2,507 | +27% | +$54.2K |
| D | 2024-08-21 | 2024-08-19 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -529 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-19 | S | D | 500 | $300.00 | 1,478.14 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-19 | S | D | 529 | $300.00 | 1,978.14 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-19 | M | A | 529 | $102.51 | 2,507.14 | D | — | — | |
| 4 | Derivative | Stock Options (Right to Buy) | 2024-08-19 | M | D | 529 | $0.00 | 0 | D | $102.51 · 2020-02-19 to 2029-02-19 | 529 Stock Options (Right to Buy) | (F1) This award vested in four equal annual installments beginning on February 19, 2020. |